Rhodes Jennifer J 4
4 · Angion Biomedica Corp. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Rhodes Jennifer J
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-03-02+175,000→ 175,000 totalExercise: $1.99Exp: 2032-03-01→ Common Stock (175,000 underlying) - Award
Stock Option (Right to Buy)
2022-03-02+100,000→ 275,000 totalExercise: $1.99Exp: 2032-03-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.